Normal view

Received today — 18 July 2025

Netflix Lifts Forecast on Ad Surge

Netflix(NASDAQ:NFLX) reported Q2 2025 earnings on July 17, 2025, with updated full-year revenue guidance of $44.8–$45.2 billion (midpoint up $1 billion from prior), and a raised operating margin target of 30%. Management highlighted accelerating member growth, robust ad sales momentum—on pace to double ad revenue this year—and continued strategic investments in original content and technology.

Margin Expansion, Revenue Acceleration, and Ad Growth Boost Full-Year Outlook

The revised full-year guidance reflects both beneficial foreign exchange (FX) movements and underlying business strength, lifting mid-point revenue projections by approximately $1 billion.

Management cited 'healthy member growth,' with ad sales on pace to roughly double in 2025, while operating expenses remain steady, driving the operating margin target up to 30% for the full year and the FX-neutral margin up by 50 basis points for 2025. The revised reported operating margin guidance now exceeds the prior range, indicating improving leverage amid accelerating revenue growth.

"So we are largely flowing through the expected higher revenues to profit margins. So that is why our updated target full-year reported margin is up a point from 29% to 30% and that 50 basis point increase in FX neutral margin is really just that revenue lift from stronger membership growth and ads relative to prior forecast flowing through the margin."
— Spencer Neumann, CFO

Higher-than-expected recurring revenue, particularly from membership and advertising, is translating into higher profit margins, strengthening the fundamental long-term earnings profile.

Global Ad Tech Rollout Unlocks Programmatic Growth and Monetization Channels

The April completion of the proprietary ad technology (ad tech) stack rollout now covers all of Netflix’s global ad markets, with subsequent data signaling a seamless transition and measurable increases in programmatic ad buying.

The company highlighted material enhancements to advertiser accessibility and targeting capabilities, imminent feature releases, and the addition of new demand sources such as Yahoo—all contributing to forward momentum in advertising as a revenue driver.

"We have completed the rollout of our own ad tech stack and the Netflix ad suite to all of our ad markets now…We have seen an increased programmatic buying. […] We are also […] going to roll out additional demand sources like Yahoo that will further open up the market for us."
— Greg Peters, Co-CEO

Owning the global ad tech infrastructure compresses go-to-market cycles and improves data-based product differentiation.

Diversified Franchise and Content Flywheel Drives Sustainable, International Engagement

The second half content slate is weighted toward globally resonant franchises, with 44 Emmy-nominated shows, new seasons of flagship series like "Squid Game," "Wednesday," "Stranger Things," and "Bridgerton," and major film releases including "Happy Gilmore 2" and a new "Knives Out."

The pipeline extends across original, licensed, animated, and live event formats—including growing international productions and sport-adjacent live rights. Notably, the company referenced ongoing member demand for increased content variety, exemplified by the TF1 partnership in France, aiming to better address local tastes in key territories.

"So what it is is about a steady drumbeat of shows and films and soon enough games that our members really love and continue to expect from us. So, like, by way of example, we had 44 individual shows nominated for Emmys this year. So that is what quality at scale looks like."
— Ted Sarandos, Co-CEO

Sustained investment in a diverse, regionally tailored slate—backed by expanding production capability and cross-format extensions—solidifies Netflix’s competitive moat, supporting global sub growth, engagement retention, and pricing power irrespective of single-title "hit" volatility.

Looking Ahead

Management projects 2025 full-year reported revenues of $44.8–$45.2 billion and an operating margin of 30%, with a third-quarter forecasted margin of 31.5%. Advertising revenue is on pace to roughly double, and the company anticipates increased engagement in the second half of 2025 due to a strong content slate.

No specific quantitative forward guidance for gaming or M&A was issued; Netflix confirmed an ongoing focus on organic growth, continued shareholder returns via repurchases, and accelerated content and technology investments.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has positions in and recommends Netflix. The Motley Fool has a disclosure policy.

Cintas Reports Record Revenue and EPS

Cintas (NASDAQ:CTAS) announced its fiscal 2025 fourth-quarter results on Thursday, July 17, with revenue up 8% year over year to $2.67 billion and diluted EPS up 9% to $1.09, with record full-year revenue of $10.34 billion and EPS growth of 16.1%. The company projects fiscal 2026 revenue of $11 billion–$11.15 billion (6.4%–7.8% growth) and EPS of $4.71–$4.85 (7%–10.2% growth), while highlighting robust recurring business performance, disciplined capital allocation, and technology-driven productivity initiatives.

The following insights examine differentiated growth, margin drivers, and capital deployment shaping long-term value creation.

Cintas' 2025 Margin Expansion Was Driven by Technology and Supply Chain Optimization

Gross margin for the Uniform Rental and Facility Services segment increased by 40 basis points to 49%, while First Aid and Safety Services delivered a 140 basis point margin increase to 56.8%. Productivity improvements stem from continued adoption of SAP enterprise systems, auto sortation in plants, and the SmartTruck platform, which together enable both cost efficiencies and improved service delivery.

"Our progress year over year reflects the positive impacts made by our excellent supply chain team, as well as cost savings initiatives such as our garment sharing, technology enhancements like our auto sortation systems in our plants, and our proprietary Smart Truck solution that makes our routes more efficient."
— Jim Rozakis, Executive Vice President and Chief Operating Officer

Ongoing technology and process investments are structurally lifting margins and generating durable cost advantages, improving the quality of earnings and positioning Cintas to maintain margin leadership regardless of macro volatility.

Cintas Saw Record Capital Deployment and Transformative M&A in Fiscal 2025

The company generated $1.6 billion in free cash flow during FY2025 and deployed $2.23 billion toward acquisitions. It was the largest year of M&A activity in nearly two decades outside of the 2017 G&K acquisition, and it deepened customer penetration and unlocking synergy value across all three route-based businesses. Additional capital priorities included $409 million in capex (4% of revenue), $612 million in dividends (forty-first consecutive annual increase), and $935 million in share repurchases.

"We invested $2.2329 billion in acquisitions in fiscal 2025 representing our largest year of M&A activity in almost 20 years, excluding our 2017 acquisition of G&K. These acquisitions span across each of our three route-based segments adding new customers, extending capacity, and delivering compelling synergies."
— Scott Garula, Executive Vice President and Chief Financial Officer

This aggressive yet balanced capital allocation strategy, anchored by substantive bolt-on acquisitions, accelerates route density, market penetration, and service breadth, creating a structural foundation for enhanced recurring revenue.

Exceptional Growth in First Aid and Safety Segment Highlights Cintas' Diversification

The First Aid and Safety segment outperformed with 18.5% organic growth, further supported by uptake in recurring revenue products such as AED rentals, eye wash stations, and water break, alongside a discrete training-related surge. Management expects this business to maintain low double-digit growth rates, demonstrating consistent end-market demand and expanding the company’s reach beyond its traditional uniform rental core.

"Our first aid business was propelled by a great performance in our training area, which tends to be more discrete and one-time in nature. Our uniform direct sale business grew 9% in the quarter, which was a really strong close to what was a bumpy year. So, a little bit more one-time in nature there."
— Todd Schneider, President and Chief Executive Officer

The strong recurring revenue growth in first aid, supported by ongoing product innovation and broad customer adoption, reinforces the company's diversification and resilience.

Looking Ahead

For FY2026, management expects revenue of $11 billion–$11.15 billion (6.4%–7.8% growth) and diluted EPS of $4.71–$4.85 (7%–10.2% growth), with operating margin forecast to exceed 23% and incrementals in the high twenties. The outlook assumes no material acquisitions or share repurchases, a 20% effective tax rate, and unchanged macro conditions. Management reiterates its commitment to mid–high single-digit organic revenue growth, double-digit expansion in first aid and fire, and disciplined capital expenditure of 3.5%–4% of revenue.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool recommends Cintas. The Motley Fool has a disclosure policy.

Stock Market Today: BigBear.ai (BBAI) Rises 15% Amid Continued Investor Interest in Defense AI


BigBear.ai (NYSE: BBAI) saw its stock close at $8.22 on Thursday, July 17, marking a significant 15.5% increase. The intraday trading showed notable volatility, ranging between a low of $7.25 and a high of $8.38.

In the context of broader market movements, BigBear.ai's performance outstripped that of key indices. The S&P 500 saw a 0.54% increase, while the Nasdaq Composite rose by 0.74%, indicating that the stock's robust rise was primarily driven by company-specific excitement rather than macroeconomic factors. Among its competitors, Palantir Technologies (NASDAQ: PLTR) and C3.ai (NYSE: AI) recorded more modest gains of 2% and 4.2%, respectively. Despite positive performances from these peer companies, BigBear.ai's 15% climb highlights investor enthusiasm toward its recent strategic partnerships in the United Arab Emirates.

The day's trading volume was approximately 205 million shares, exceeding its 50-day average of 143 million shares and the 200-day average of 96 million shares. This heightened activity suggests increased investor interest, likely spurred by the company's recent advancements and strategic initiatives in defense technology. Overall, BigBear.ai's notable rally reflects growing market confidence in its role within the evolving defense AI landscape, signaling potential for sustained growth.

Should you invest $1,000 in BigBear.ai right now?

Before you buy stock in BigBear.ai, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and BigBear.ai wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $674,281!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,050,415!*

Now, it’s worth noting Stock Advisor’s total average return is 1,058% — a market-crushing outperformance compared to 179% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of July 15, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool recommends C3.ai. The Motley Fool has a disclosure policy.

OFG Bancorp Reports Record Q2 Results

OFG Bancorp(NYSE:OFG) reported its Q2 2025 results on July 17, with assets exceeding $12.2 billion and loans topping $8.2 billion, driving a 6.5% year-over-year increase in diluted EPS to $1.15. The company raised its guidance for full-year loan growth to nearly 6%, initiated a new $100 million share buyback, and maintained a CET1 ratio of 13.99%, while net interest margin settled at 5.31% due to proactive liquidity management.

Digital Adoption Drives Relationship Deepening and Account Growth

New net customer growth reached 4%, supported by increased digital engagement and the rollout of new online products like Oriental Marketplace and a U.S. government money market fund. Nearly all routine retail teller transactions and 70% of loan payments occurred through digital and self-service channels, demonstrating tangible customer migration to lower-cost, scalable delivery methods.

"During the second quarter, nearly all of our routine teller retail customer transactions and deposits, as well as 70% of retail loan payments, were made through our digital and self-service channels. This was driven by continued year-over-year growth in digital enrollment, digital loan payments, virtual teller utilization, and 4% new net customer growth."
— Jose Rafael Fernandez, Chief Executive Officer and Chairman of the Board of Directors

This accelerated digital transformation enhances efficiency and supports account growth.

Strategic Liquidity Build Positions for Above-Plan Commercial Loan Growth

End-of-period loans held for investment jumped by $328 million from the previous quarter to $8.2 billion, with new originations up 38% quarter-over-quarter and a robust U.S. and Puerto Rico commercial pipeline in place. Management proactively secured a $200 million Federal Home Loan Bank advance at 4.13% alongside $82.5 million of brokered deposits to support rising loan demand as average loan balances grew close to 2% sequentially.

"[W]e decided to accelerate and put funding to the post with a good rate because at the end, it's 4.13. We have margin if we put it in cash, but we wanted to anticipate that liquidity at that moment. We were opportunistic. And now we have flexibility to continue investing going forward with the opportunities."
— Maritza Arizmendi, Chief Financial Officer

This deliberate approach to securing low-cost, flexible funding ahead of forecast loan demand ensures OFG can support lending targets while maintaining capital discipline and credit underwriting standards.

Improved Asset Quality from Enhanced Underwriting and Favorable Economic Environment

Net charge-offs declined to $13 million, down $7.6 million sequentially and delivering a charge-off rate of 0.64%, while early and total delinquency rates remained manageable at 2.46% and 3.59%, respectively. Management attributed these metrics to improved consumer and commercial loan vintages, with risk model recalibration since 2022 resulting in persistently lower loss rates and a more resilient portfolio, despite modest quarter-to-quarter seasonal variation.

"So it's a new vintage coming in, better vintages coming in that we adjusted back in 2022. So those new vintages with better credit performance are going to continue coming into the statistics. So that's going to continue stabilizing and repairing hopefully, better charge-off rates and number loan and delinquency rates than previous vintages."
— Cesar Ortiz, Chief Risk Officer

Looking Ahead

Management expects retail deposit growth to persist throughout the second half of 2025 and into 2026, and raised loan growth expectations for 2025 to nearly 6%, up from a prior guidance range of 3% to 4%. Noninterest expenses are anticipated to remain within $95 million to $96 million per quarter, excluding discrete items, with a full-year effective tax rate forecast of 24.9% for 2025, absent unique tax benefits.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Insteel Industries Fiscal Q3 Profit Jumps

Insteel Industries (NYSE:IIIN) reported its fiscal Q3 2025 earnings on July 17, delivering net income of $15.2 million ($0.78 per share), a gross margin expansion of 650 basis points to 17.1%, and a year-over-year shipment volume increase of 10.5%. The earnings call highlighted aggressive pricing actions, higher inventories, enhanced financial flexibility, strategic responses to tariff uncertainty, and improved integration of recent acquisitions, all against the backdrop of supply constraints and mixed construction indicators.

Margin Expansion via Strategic Pricing and Inventory Positioning

Gross profit (GAAP) rose $15.4 million year over year to $30.8 million, with average selling prices increasing 11.7% year over year and 8.2% sequentially from fiscal Q2, while the inventory position at quarter-end represented 2.7 months of shipments on a forward-looking basis, based on forecast fiscal Q4 shipments. The company is leveraging both timely price actions and first-in, first-out inventory practices to manage a volatile cost environment.

"Performance was driven primarily by an expansion of spreads as the increase in average selling prices outpaced the rise in raw material costs during the quarter. As we have noted on prior calls, during periods of strong demand and rising steel rod prices, financial results tend to benefit from both the timely implementation of price increases, enabling us to offset higher replacement costs, and the favorable impact of lower-cost inventory flowing through under our first-in, first-out accounting methodology."
— Scot Jafroodi, Vice President, CFO, and Treasurer

This adept management of both pricing power and inventory flow positions Insteel Industries to preserve and potentially enhance profitability amid ongoing raw material volatility.

Risk Mitigation Amid Tariff Uncertainty and Supply Constraints

Section 232 tariffs on steel, which doubled from 25% to 50% effective in June, combined with persistent U.S. wire rod shortages and resulted in the company importing 25% to 30% of its steel requirements. Import exposure is contained at roughly 10% of revenue, according to management, yet critical operational materials remain exposed to sometimes ambiguous and shifting enforcement of the new U.S. tariffs.

"Imports of wire rod are essential for Insteel Industries, Inc. today, as there is insufficient domestic wire rod production capacity to supply domestic demand. Our choice is to pursue offshore sourcing or to scale back operations to the point that our ability to support customers is threatened."
— H.O. Woltz III, President and CEO

The company's supply-chain adaptability has allowed it to sustain production continuity, but exposes it to elevated input cost risk and regulatory unpredictability.

Acquisition Integration Accelerates Capacity and Operational Flexibility

Recent acquisitions, particularly those of Engineered Wire Products (EWP) and O'Brien Wire Products, contributed to shipment growth and necessitated operational restructuring. The company took $843,000 in related restructuring charges in the quarter, and expenses related to those new assets' integration could continue through Q1 2026. Backlogs have grown due to raw material constraints, but execution at acquired plants, especially the Upper Sandusky facility, has met or exceeded expectations.

"We moved a lot of products around, so there is no real comparable performance between last year and this year. It is just a fundamentally different operating approach. But they obviously know what they are doing, and they are productive. And we know how to quantify those things."
— H.O. Woltz III, President and CEO

The successful integration of these acquisitions is enhancing operational flexibility and productivity, positioning the company to better manage demand fluctuations and capitalize on future growth opportunities.

Looking Ahead

Management expects GAAP gross margins to remain stable, supported by elevated demand, favorable inventory costs, and higher plant operating rates. It cut its guidance for fiscal 2025 capital expenditures to $11 million from $17 million due to integration resource allocation, with no major projects canceled. Capex projections for 2026 will be forthcoming next quarter. The company affirmed a robust demand environment through the fiscal year's end, but offered no formal shipment or revenue forecasts, citing unpredictability around tariffs and the economic outlook.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Stock Market Today: Lucid Surges on Uber's $300 Million Robotaxi Deal


Lucid Group (NASDAQ: LCID) shares skyrocketed 36.2% to close at $3.12 on Thursday, marking one of the electric vehicle (EV) maker's strongest single-day performances of the year. The dramatic surge was fueled by two significant announcements: a major partnership with Uber Technologies (NYSE: UBER) involving a $300 million commitment to deploy 20,000 Lucid Gravity SUVs as robotaxis starting in 2026, and the company's filing for a 1-for-10 reverse stock split aimed at boosting share price and attracting institutional investors.

The stock's performance vastly outpaced broader market indices, with the Nasdaq Composite rising just 0.74% and the S&P 500 gaining 0.54%. Among competitors, Tesla (NASDAQ: TSLA) dipped 0.7% to $319.41, while Rivian (NASDAQ: RIVN) posted a more modest gain of 4.1% to $12.90, highlighting the Lucid-specific nature of today's market reaction.

Trading volume reached an extraordinary 934.5 million shares, nearly seven times the 50-day average of roughly 137.7 million shares. This exceptional volume surge, combined with the stock's significant distance from its 52-week high ($4.43), reflects the market's strong response to Lucid's strategic initiatives. While the robotaxi partnership offers a potential new revenue stream, investors appear to be revaluing the company's prospects in the competitive electric vehicle landscape.

Should you invest $1,000 in Lucid Group right now?

Before you buy stock in Lucid Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Lucid Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $674,281!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,050,415!*

Now, it’s worth noting Stock Advisor’s total average return is 1,058% — a market-crushing outperformance compared to 179% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of July 15, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has positions in and recommends Tesla and Uber Technologies. The Motley Fool has a disclosure policy.

Stock Market Today: WBD Continues Uptrend Amid Ongoing Optimism Over June's Streaming Split Decision


Warner Bros. Discovery (NASDAQ: WBD) shares climbed 2.07% to close at $12.84 on Thursday, outpacing broader market gains as investors continue to respond positively to developments regarding the company's linear division spin-off. Trading volume surged to approximately 110.5 million shares, nearly double the 50-day average of 66.7 million, indicating heightened interest and conviction behind the price movement.

The S&P 500 and Nasdaq Composite both traded near all-time highs but posted more modest gains of around 0.54% and 0.74% respectively. Industry peers showed positive movement as well, with Walt Disney (NYSE: DIS) rising 1.99% to $122.21 and Comcast (NASDAQ: CMCSA) gaining 0.87% to $34.70, though neither matched WBD's relative performance.

Technically, WBD shares are trading near their 52-week high, reinforcing a bullish breakout pattern that has attracted additional investor attention. The dramatic volume spike of approximately two times normal levels suggests possible institutional participation (hedge funds) as the company advances its strategic initiatives. Today's momentum and trading activity signal ongoing investor confidence in Warner Bros. Discovery's evolving media business strategy.

Should you invest $1,000 in Warner Bros. Discovery right now?

Before you buy stock in Warner Bros. Discovery, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Warner Bros. Discovery wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $674,281!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,050,415!*

Now, it’s worth noting Stock Advisor’s total average return is 1,058% — a market-crushing outperformance compared to 179% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of July 15, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has positions in and recommends Walt Disney and Warner Bros. Discovery. The Motley Fool recommends Comcast. The Motley Fool has a disclosure policy.

Travelers Reports a Q2 Profit of $1.5 Billion

The Travelers Companies (NYSE:TRV) reported results for the second quarter of 2025 on July 17, highlighting $1.5 billion in core income ($6.51 per share) and a core return on equity of 18.8%. The quarter included $11.5 billion in net written premiums, $809 million in capital returned to shareholders, and the announcement in May of the divestiture of its Canadian business for $2.4 billion.

Sharp Improvement in Underwriting Profitability Across All Segments

Core income reached $1.5 billion, reflecting an 18.8% core return on equity, with underlying underwriting income up 35% to $1.6 billion pretax. Net earned premiums rose 7% to $10.9 billion as all three business segments reported underlying combined ratios below or near 90%, including a personal insurance underlying combined ratio of 79.3%.

"Underlying underwriting income of $1.6 billion pretax was up 35% over the prior year quarter, driven by 7% growth in net earned premiums to $10.9 billion and an underlying combined ratio that improved 3 points to an excellent 84.7%. All three segments contributed to these terrific results with strong net earned premiums and excellent reported and underlying profitability."
— Alan Schnitzer, Chairman and CEO

The breadth and magnitude of underwriting improvements signal enhanced risk selection and disciplined pricing, directly reinforcing the company’s sustained profit momentum throughout volatile industry conditions.

Disciplined Capital Management and Strategic Portfolio Optimization

Adjusted book value per share was $144.57 at quarter's end, up 14% from a year prior, while operating cash flows were $2.3 billion and the board's share repurchase authorization stood at $4.3 billion. The $2.4 billion sale of most of the company's Canadian operations, at 1.8 times book value, announced in May, demonstrates aggressive internal capital reallocation favoring higher-return opportunities without shrinking core business capabilities.

"Disciplined capital management isn't only about deciding how to deploy the marginal dollar. It's also about continually and rigorously reassessing the capital we have already deployed and whether it's still delivering the best long-term value."
— Alan Schnitzer, Chairman and CEO

This measured divestiture affirms management’s willingness to optimize the business mix, enhancing shareholder value independent of broader M&A trends or market timing considerations.

Fixed Income Portfolio Growth Drives Investment Income Upside

The investment portfolio’s assets surpassed $100 billion (excluding net unrealized loss), generating $774 million in after-tax net investment income. After-tax net investment income increased by 6% from the prior-year quarter. New money rates as of June 30, 2025, were more than 100 basis points above the embedded portfolio yield, boosting earnings visibility for the remainder of the year and into 2026.

"Fixed income NII should continue to increase beyond 2025 as the portfolio continues to grow and gradually turns over, with higher yields replacing maturing yields."
— Dan Frey, CFO

The expanded, higher-yielding fixed income base is expected to increase net investment income.

Looking Ahead

Management projects a full-year expense ratio of 28% to 28.5% for 2025, targets $700 million in additional share repurchases in 2026 from the proceeds of the Canadian divestiture, and expects fixed income net investment income after tax of approximately $770 million in Q3 and $805 million in Q4. Management expects to relax most of its personal insurance rate and capacity restrictions by the end of 2025, reinforcing the outlook for continued premium growth and robust underwriting margins. No incremental guidance was provided regarding M&A, but management reiterated its focus on opportunities that demonstrably improve returns or strategic capabilities.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

AAR Posts Record Q4 Sales Growth

Aircraft maintenance service specialist AAR Corp. (NYSE:AIR) reported fiscal 2025 fourth-quarter earnings on Wednesday, July 16, that highlighted its record full-year revenue of $2.8 billion (up 20%). It also reported a 32% increase in Q4 adjusted EPS to $1.16 (from $0.88 a year ago). Management confirmed 14% organic sales growth in Q4 and net leverage improved to 2.7x in Q4, further aligning with long-term deleveraging targets and ongoing portfolio optimization.

The following insights delve into material business developments impacting AAR's growth outlook, operational leverage, and competitive positioning.

Record Margin Expansion and Deleveraging Signal Strategic Execution for AAR

Adjusted EBITDA margin expanded by 140 basis points to 11.8% in fiscal 2025, and the reduction in net leverage from 3.06x to 2.72x in Q4 was fueled by $51 million in Q4 operational cash flow and $48 million from the landing gear divestiture. Furthermore, AAR repurchased $10 million of shares in Q4 at an average cost of $52.37 per share.

"We delivered record full-year results of $2.8 billion, up 20% over the prior year. Adjusted EBITDA margin increased 140 basis points to 11.8% in fiscal 2025, which reflects strong growth across our core segments. We generated record adjusted diluted earnings per share of $3.91 compared to $3.33 last year. We continue to reduce our net leverage, and our strong balance sheet, along with our disciplined capital allocation strategy, has us well-positioned for investments that will drive continued growth."
— John Holmes, Chairman, President and Chief Executive Officer

The combination of improved profitability and a strengthened balance sheet increases AAR's operational flexibility and potential for both organic and inorganic scale.

Trax Acquisition and Digital Strategy Deliver Accelerated, High-Quality Revenue Growth

Trax secured a multi-year contract with Delta Air Lines and is positioned to benefit from both new wins and legacy client upgrades that can quadruple or quintuple average license values. Management highlighted that digital and IP-enabled offerings -- led by Trax's eMRO and eMobility solutions -- represent a differentiated, high-margin growth vector within AAR's evolving portfolio.

"Our goal is to, again, double the revenue of Trax. And we are excited about all those opportunities."
— John Holmes, Chairman, President and Chief Executive Officer

Management expects that customer upgrades will unlock further margin expansion, structurally increasing recurring, software-driven revenue streams less exposed to cyclical aviation maintenance spending.

Parts Supply and Distribution Outperformance Underscores AAR Market Share Gains

Parts Supply segment sales in Q4 surged 17% year over year to $306 million, powered by over 20% organic growth in new parts distribution. Distribution now anchors AAR as the foremost independent provider globally, positioning the business for continued partnership opportunities with OEMs (original equipment manufacturers).

"Distribution led the way this quarter with another quarter of 20% plus growth we mentioned, we saw that throughout the year. So distribution has really been the driver there. ... within distribution, you have had a relatively even split in terms of growth in the commercial market and the government market."
— John Holmes, Chairman, President and Chief Executive Officer

Sustained above-market parts distribution growth of over 20% signals structural share gains and reinforces AAR's ability to drive consistent, outsized returns in both expansionary and constrained industry environments

Looking Ahead

For fiscal 2026, AAR guides to organic sales growth approaching 9%, based on its FY2025 adjusted sales base of $2.68 billion, with Q1 expected to deliver 6%–11% sales growth and adjusted operating margins between 9.6%–10%. The company is positioned to realize the full $10 million in annual cost synergies from the Product Support acquisition, and the continued rollout of digital and capacity investments is expected to drive further operating margin improvement. Management confirmed that additional M&A remains a strategic focus, with repurchases prioritized over dividend reinstatement, should leverage fall comfortably within the 2.0x–2.5x range.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool recommends Delta Air Lines. The Motley Fool has a disclosure policy.

Abbott Reports 12% Growth in Device Sales

Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.26, an 11% increase compared to the prior year and a 16% rise compared to the first quarter. Management reaffirmed its view of 2025 as a transition year marked by transient headwinds -- primarily in diagnostics -- while affirming a commitment to high single-digit percentage organic sales growth and double-digit non-GAAP EPS expansion amid robust margin gains.

Structural Heart and Electrophysiology Drive Medical Devices Leadership

Revenues from the company's medical devices segment grew 12% in the quarter, fueled by double-digit gains in diabetes care, heart failure, electrophysiology, and rhythm management, with continuous glucose monitor sales reaching $1.9 billion (up 19.5%). The launch of the Volt PFA catheter and the completion of enrollment in the PACIFLEX DUO US trial reflected its rapid innovation cadence in the electrophysiology indication.

"In electrophysiology, we had several key accomplishments in the quarter, including delivering another quarter of double-digit sales growth, initiating the launch of our new Volt PFA catheter, and completing enrollment ahead of schedule in our PACIFLEX DUO US pivotal trial."
— Phil Boudreau, Executive Vice President of Finance & Chief Financial Officer

These milestones underscore an agile R&D model that rapidly iterates and commercializes next-generation technologies, fortifying Abbott Laboratories' long-term position in high-growth and high-barrier medtech categories.

Diagnostics Faces Temporary but Significant Headwinds, Core Lab Remains Resilient

Diagnostics revenue declined 1.5%, with a $700 million full-year 2025 expected headwind from declining COVID test sales and China Core Lab volume-based procurement, although Core Lab Diagnostics (excluding China) grew 8%. Sales growth in Latin America region saw growth in the high teens, evidencing demand strength despite regional variance.

"So really the challenge that we've had is twofold here. It's really a drop-off on our COVID test sales and some challenges in the China Core Lab market together with some changes that we've seen in the U.S. foreign aid funding for HIV testing. So you look at that and say, okay, I'm not sure these are impacts that are 100% definite in the second half of the year, but I'm not gonna sit here and try and kind of forecast what COVID testing is gonna do. We had expected to see a China recovery in volume. We knew the price impact in China Core Lab, David, and we rolled that into our guidance. We had expected a market volume recovery to start happening in quite frankly, starting in Q2. We haven't seen that, so we've moved that out and into, you know, into Q4. But you put all that together, it's together with the U.S. with the funding for HIV testing that's over a billion dollars of, I guess, of headwind. And even with that billion dollars, we're still forecasting high single-digit growth and absorbing the impact of tariffs. We now expect to be just under $200 million of impact. FX, you know, as Phil kind of said in his comment, is still a headwind versus prior year on the EPS side, but much less of a headwind than what we had originally kind of anticipated back in January and quite frankly, people too. So that helps offset some of the tariff impact. So, yeah, I put this all together, and it'll be nice, David, to see these headwinds behind us next year. And then as you look to next year, you got all this great launch activity across all the businesses, whether it's Volt in the U.S., Tactiflex Duo internationally, the dual analyte sensor, the launch of the new Alinity system, the biosimilar kind of rollout. So I look at all of that, and I say, okay. You've got this headwind that we're facing here. Still, we're committing to high single-digit growth and double-digit EPS growth. And then as you look into 2026, those headwinds aren't gonna be there. And then you've got all this kind of great momentum I'm sure we'll talk about in other parts of the business. So I looked at 2026. I know what the consensus is. They look very reasonable to me, in that range of high single digits, double EPS. It's in line with our historical growth. It's in line with the guidance we've given this year, and it's in line with, you know, what our long-term sustainable growth targets are. So, yeah, it'll be good to see these elements here that I've just kind of highlighted that are specific to diagnostics. And I'll just take it a step further here. I mean, you look at our, and I mentioned this in the opening comments here. Our Core Lab business outside, and I hate doing this, but I think it gets context. If you look at the U.S., it was up 7%, 8%. The European region was up 8%. Our Latin America region was high teens. So our Core Lab business is doing very well. Alinity is doing very well. We just got this issue that, you know, we're gonna have to go through this year as it relates to VBP and the disruption that happened in our core lab business in China. But we're still very bullish on this segment. We still believe it's a very important part of the healthcare system. So like I said, looking forward to these headwinds being behind us, and we're well set up for next year."
— Robert Ford, Chairman & Chief Executive Officer

Management's ability to absorb outsized diagnostics shocks and maintain high-single-digit organic growth reflects strong portfolio diversification and operational discipline amid persistent global market volatility.

Pipeline Momentum and Biosimilars Expand Future Growth Potential

Launch activity scheduled for Volt in the U.S, Tactiflex Duo internationally, a dual analyte (glucose/ketone) sensor, next-generation Alinity systems, and the debut of biosimilars in key emerging markets reveal the broad innovation depth in the pipeline. Abbott's Established Pharmaceutical Division completed 10 biosimilar submissions to regulators targeting 2026 rollouts.

"This is an opportunity for us to really look at how do you sustain that growth rate in this business. I think we'll leverage our existing presence in these emerging markets. We're gonna bring cutting-edge medicines into these countries that I say that historically lack the access. So I think this can be a nice contributor here to our growth in this business in the next few years."
— Robert Ford, Chairman & Chief Executive Officer

Combining established market platforms with new biosimilars leverages Abbott's reach for growth outside mature geographies while requiring relatively limited incremental SG&A investments, enhancing its long-term ROIC prospects.

Looking Ahead

Abbott forecasts adjusted EPS in the range of $1.28 to $1.32 for Q3 and expects a favorable foreign exchange impact of approximately 2% on reported sales, with the full-year FX impact now anticipated to be neutral. Management called the current Street consensus for 2026 "very reasonable," as it expects recent headwinds to abate with pipeline launches supporting acceleration. No explicit biosimilar revenue targets or granular 2026 guidance figures were provided in the earnings call.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool has a disclosure policy.

Texas Capital Bancshares Profit Doubles

Texas Capital Bancshares (NASDAQ:TCBI) reported its second-quarter 2025 earnings on July 17, 2025, delivering a 104% increase in adjusted EPS and 100% growth in adjusted net income year over year, supported by 16% adjusted revenue growth. Management reaffirmed guidance for low double-digit percentage revenue growth for the full year and highlighted a record tangible book value of $70.14 per share and robust capital ratios, with a CET1 ratio of 11.45%. The transcript reveals transformative strategic execution, enhanced risk positioning, and granular insights into accelerating fee and loan growth opportunities.

Milestone Financial Transformation Fuels Record Profitability

Adjusted pre-provision net revenue reached $120.5 million, a 52% year-over-year increase, as both net interest income and adjusted fee-based revenues showed double-digit percentage gains. The tangible-common-equity-to-tangible-assets ratio rose to 10.04%, reflecting disciplined growth amidst proactive capital allocation and balance sheet enhancements.

"Year-over-year quarterly earnings growth accelerated materially during the quarter, with adjusted total revenue increasing 16%, adjusted net income to common [stockholders] up 100%, adjusted earnings per share expanding 104%, and adjusted return on average assets of 1.02%, nearing the 1.1% goal we set out for 2025."
— Rob Holmes, Chairman, President, and CEO

The achievement of sector-leading profitability and strengthened capital levels positions Texas Capital Bancshares as a structurally improved, more resilient regional bank, markedly enhancing its long-term earnings power and downside protection.

Fee Income and Investment Banking Drive Strategic Diversification

Treasury product fees surged 37% year-over-year to a record, marking increases in eight of the last 12 quarters, while investment banking and trading income climbed 43% quarter over quarter and 4% year over year despite periods of market inactivity. Management reported the ongoing build-out of equities, research, and trading operations, now covering 72 companies and expected to further scale in the second half of 2025.

"Quarterly treasury product fees have now increased eight of the last 12 quarters, demonstrating the sustainability of our trajectory and commitment to being a premier payments bank. Early and substantial investments in these products and services have returned the expected outcomes, which as they scale, will continue to enhance profitability."
— Rob Holmes, Chairman, President, and CEO

By expanding fee-based income streams and commercial banking capabilities, Texas Capital Bancshares increases revenue stability while fortifying its competitive positioning and creating multiple levers for long-term margin expansion.

Proactive Credit and Capital Management Underpins Robust Risk Posture

The bank boosted its allowance for credit loss by $2 million to a record $334 million, representing 1.79% of loans held for investment (LHI) excluding mortgage finance, while criticized loans declined by 26% year over year. The CET1 capital ratio remained high at 11.45%, and the company repurchased approximately 318,000 shares (0.7% of the prior quarter's shares outstanding) for $21 million, reflecting disciplined capital deployment.

"[T]otal criticized loans decreased $222 million or 26% year over year. Criticized loans to total LHI decreased to 2.66%, the lowest level since 2022, with broad-based improvements across both C&I and CRE. The reserve coverage ratio remained strong at 2.9 times nonaccrual loans, which experienced a modest increase of $20 million this quarter to levels in line with those experienced over the last 12 months."
— Matt Scurlock, CFO

This balance sheet vigilance, paired with conservative credit assumptions and substantial loss-absorbing capacity, reduces tail risk and supports sustained growth in both lending and deposit-gathering in volatile economic conditions.

Looking Ahead

Management reaffirmed full-year guidance for low double-digit percent revenue growth for 2025 and expects quarterly noninterest income to reach $60 million to $65 million in Q3, supported by $35 million to $40 million in investment banking fees in Q3; full-year noninterest income guidance is now $230 million to $240 million. Noninterest expense guidance decreased to mid to high single-digit percent growth for the full year, with Q3 and Q4 expenses forecast in the mid to high $190 million range, reflecting structural efficiencies and a targeted capability build-out. The full-year provision expense outlook remains at 30 to 35 basis points of loans held for investment excluding mortgage finance, and management specifically anticipates achieving a 1.1% quarterly return on average assets in the second half of the year.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

First Industrial EPS Climbs 10.5% In Q2

Key Points

  • Earnings per share reached $0.42 for Q2 2025, exceeding the $0.38 analyst estimate.

  • Revenue grew to $180.2 million in Q2 2025, surpassing consensus expectations and increasing 9.8% year over year.

  • Funds From Operations (FFO) per share/unit (diluted) was $0.76, compared to $0.66 for Q2 2024, a 15.2% increase, with ongoing strength in rental and same store NOI growth.

First Industrial Realty Trust (NYSE:FR), a real estate investment trust focused on logistics and industrial properties in major U.S. markets, reported fiscal 2025 second-quarter results on Wednesday, July 16, that topped analysts' consensus expectations. Earnings per share (EPS) of $0.42 beat the forecasted $0.38, while Q2 revenue came in at $180.2 million, ahead of the $177.6 million consensus estimate.

The quarter showed strong operational execution with expansion in FFO per share, but revealed a slight decline in occupancy rates. Overall, the period highlighted notable rental growth, a disciplined development strategy, and a robust capital position, though occupancy and leasing velocity faced some recent pressure.

MetricQ2 2025Q2 2025 EstimateQ2 2024Change (YOY)
EPS$0.42$0.38$0.397.7%
Revenue$180.2 million$177.6 million$164.1 million9.8%
FFO per share$0.76N/A$0.6615.2%
Same-store NOI growth8.7%N/A5.6%310 bps
In-service occupancy94.2%N/A95.3%(110 bps)

Source: First Industrial Realty. Note: Analysts' consensus estimates provided by FactSet. YOY = Year over year. Same-store net operating income (NOI) growth is on a cash basis, before termination fees. bps = basis points.

Business Overview and Strategic Focus

The company operates as a real estate investment trust (REIT) specializing in the ownership, development, and management of logistics and industrial facilities. Its portfolio is concentrated in 15 key U.S. logistics markets, many of which are coastal regions with limited land supply. This focus allows it to benefit from consistently strong demand, long-term rent growth potential, and capital appreciation.

Recently, the company's strategy has focused on driving internal rental growth through lease renewals, rent escalations, and targeted development projects. Disciplined investment in high-demand, supply-constrained markets and financial management, including prudent debt issuance and maintaining capital flexibility, remain key to its success. Management's ability to respond to market demand and control operating expenses is also vital.

Quarter Highlights: Growth, Leasing, Financials, and Capital Activity

The second quarter saw robust gains in rental revenue and profitability. Revenue (GAAP) was $180.2 million, compared to $164.1 million in Q2 2024, a 9.8% increase. Same store net operating income (NOI), a non-GAAP metric that tracks the performance of properties held for at least a year and eliminates distortions from acquisitions and dispositions, rose 8.7%. FFO per share/unit (diluted) grew 15.2% compared to Q2 2024, reflecting both stronger recurring earnings and conservative capital management.

Leasing metrics showed both notable strengths and some emerging caution signals. Rental rates on new and renewal leases increased 28.0% on a cash basis and 47.1% on a straight-line basis, meaning that, accounting for contractual rent escalations, future revenue from these leases should remain strong. Excluding a large fixed-rate renewal, cash rental uplifts rose 46.1%, underscoring strong tenant demand. However, In-service occupancy was 94.2% at the end of the quarter, compared to 95.3% at the end of Q1 2025 and Q2 2024, which management attributes to planned move-outs and unleased newly-developed space. Management indicated that 88% of space expiring in 2025 is already addressed, helping ease concerns about rollover risk.

Development activity featured the start of two new projects -- one in Dallas at 176,000 square feet with a $23 million investment and another in Philadelphia at 226,000 square feet and $31 million invested. Both target yields near 8%, with a focus on smaller tenants and underserved segments. The company also leased part of a newly developed building in Orlando and completed a small asset sale in Detroit for $2 million. Property expenses increased by 5.6% compared to Q2 2024, while general and administrative costs declined 12.4% compared to Q2 2024.

From a balance sheet and capital markets perspective, the company issued $450 million in senior unsecured notes at 5.25% due in 2031, its first public bond since 2007. The company’s senior unsecured debt was upgraded to BBB+ by Fitch Ratings during the quarter. Total debt at quarter-end increased to $2.393 billion as of June 30, from $2.209 billion at the end of 2024, reflecting ongoing development activity. Importantly, there are no major debt maturities until 2027, assuming all extension options are exercised, giving it more flexibility for managing growth and refinancing risk.

The quarterly dividend was raised 20.3% to $0.445 per share for Q1 2025, continuing a series of increases. This dividend growth supports shareholders and underscores confidence in the company's earnings trajectory and cash flow stability.

Looking Ahead: Guidance and Key Trends

Management reaffirmed its full-year fiscal 2025 guidance. The company expects GAAP net income per share between $1.53 and $1.61 for FY2025 and FFO per share between $2.88 and $2.96. Average in-service occupancy is forecasted at 95% to 96% for 2025, and management projects same-store NOI growth of 6% to 7% for 2025 before termination fees. Guidance for general and administrative expenses is $40.5 million to $41.5 million for 2025. All guidance excludes potential impacts from future, uncommitted acquisition, sales, or financing actions.

Management cautioned about persistent uncertainty from U.S. trade tariffs, noting some leasing decisions have slowed or paused as tenants wait for policy clarity. The company ran a sensitivity analysis showing that if the largest new developments are not leased up by the end of the year, the potential impact on FFO per share would be limited to $0.02, which is still within management’s stated full-year 2025 guidance range. The company has achieved a cash rental rate increase of approximately 33% on leases signed to date in 2025, reflecting 88% of 2025 expirations by square footage.

Note: Revenue and net income are presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

South Plains Financial Grows Loans in Q2

South Plains Financial(NASDAQ:SPFI) reported Q2 2025 results on July 16, 2025, posting diluted EPS of $0.86 (including a $0.09 one-time benefit), net income of $12.2 million, and net interest margin expansion to 4.07%. The quarter featured modest loan growth, core deposit mix improvement, capital ratio expansion, and proactive hiring, but also underscored headwinds from elevated loan payoffs.

Capital Position Enables Simultaneous Organic Growth and M&A Capacity

South Plains Financial ended the quarter with a consolidated common equity tier 1 risk-based capital ratio of 13.86% and a tier 1 leverage ratio of 12.12%. Tangible common equity to tangible assets rose 34 basis points to 9.98% quarter-over-quarter, with tangible book value per share reaching $26.70. Mergers and acquisitions remain part of its growth strategy.

"We continue to have a strict criteria for a deal, and are only interested in acquiring a bank with the right culture, an asset liability profile that meets our needs, a stable deposit base, and at a valuation that makes sense. We can be patient given the organic growth opportunities that we have across our markets. Importantly, we believe that we are in a strong position to capitalize on opportunities to drive growth as the bank and the company each significantly exceed the minimum regulatory capital levels necessary to be deemed well-capitalized. At June 30, 2025, our consolidated common equity tier one risk-based capital ratio was 13.86% and our tier one leverage ratio was 12.12%."
— Curtis Griffith, Chairman & CEO

Loan Pipeline and Geographic Diversification Support Long-Term Growth, Despite Near-Term Headwinds

Loans held for investment rose $23.1 million, or 3% annualized, as broad-based gains offset $49.1 million in multifamily loan payoffs and a $26 million decline in major metro (Dallas, Houston, El Paso) balances to $1.01 billion. New hiring in growth markets, particularly Dallas, is expected to reinforce long-term origination levels. Management expects full-year 2025 loan growth at the lower end of the "low to mid-single-digit" range as near-term payoffs weigh on net growth, but views hiring as the lever that can drive a subsequent acceleration.

"If you look at the hires that we're trying to do, our intention is not to leave it at that level. And so our goal is to be driving that up probably more to the mid to high end after '25. I feel really good about what we're trying to accomplish on some of the hires that we're actually doing."
— Cory Newsom, President

The deliberate investment in experienced relationship bankers is designed to expand origination capacity and produce a structural uplift in both loan and core deposit growth.

Deposit Mix Enhancements and Margin Management Drive Core Earnings Quality

Core net interest margin, excluding one-time items, rose 9 basis points to 3.9%, driven by a 5 basis point drop in cost of deposits (down to 2.14%) after noninterest-bearing deposits increased $32.3 million, public fund deposits declined, CD rates continued to drop, and the deposit mix shifted towards lower-cost funding. Exception-based pricing and treasury management services are maturing, and noninterest income comprised 22% of revenues.

"Noninterest-bearing deposits increased $32.3 million in the second quarter. This, coupled with the decline in public fund deposits, contributed to total deposits ratio increasing to 26.7% in the second quarter from 25.5% in the linked quarter. The mix shift change in deposits, along with the continued drop in CD rates, contributed to the 5 basis point decline in our cost of deposits."
— Steve Crockett, CFO & Treasurer

Looking Ahead

Management expects full-year 2025 loan growth at the lower end of its low- to mid-single-digit percentage range due to ongoing but moderating loan payoffs. Loan yields are guided to stabilize near current levels in the absence of FOMC rate moves. No explicit quantitative EPS or revenue guidance was provided.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,058%* — a market-crushing outperformance compared to 179% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Abbott Reports 10.5% EPS Growth for Fiscal Q2

Key Points

  • Q2 revenue beat expectations at $11.14 billion, up 7.4% year over year.

  • Adjusted EPS exceeded estimates, reaching $1.26 for Q2 2025, representing 10.5% growth year over year.

  • Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure.

Abbott Laboratories (NYSE:ABT), a global healthcare company known for its medical devices, diagnostics, nutrition, and pharmaceuticals, reported fiscal 2025 earnings on Thursday, July 17, that narrowly topped analysts' consensus estimates. Q2 revenue climbed to $11.14 billion, surpassing the analyst estimate of $11.06 billion, and adjusted earnings per share came in at $1.26, beating the consensus by $0.01.

These results reflect robust year-over-year growth, especially in the company’s Medical Devices segment, which reported year-over-year sales growth of 13.4%, but also highlight continued headwinds in its Diagnostics business, mainly in China. Overall, the company achieved margin expansion and affirmed management’s full-year outlook despite tariff pressures and competitive and regulatory challenges overseas.

MetricQ2 2025Q2 2025 EstimateQ2 2024Change (YOY)
Adjusted EPS$1.26$1.25$1.1410.5%
Revenue$11.14 billion$11.06 billion$10.38 billion7.4%
Adj. operating margin22.9%21.9%100 bps
Net earnings$2.21 billion$2.00 billion10.5%

Source: Abbott Laboratories. Note: Analysts' consensus estimates for the quarter provided by FactSet. YOY = Year over year. bps = basis points.

Understanding Abbott Laboratories’ Business

Abbott Labs operates across four main segments: medical devices, diagnostics, nutrition, and pharmaceuticals. Its product range includes continuous glucose monitors for diabetes care, implantable heart devices, laboratory diagnostic analyzers, and nutritional products such as Ensure and Glucerna. The company serves customers in over 160 countries, generating a significant portion of sales internationally.

The company’s ongoing strategy centers on technological innovation, shown in products like its FreeStyle Libre system for continuous glucose monitoring, and compliance with evolving global health regulations. Its global footprint supports market access and supply chain resilience. Success depends on delivering new technology, defending market share, and adapting to changing healthcare policies and competitive pressures.

Second-Quarter Highlights

The Medical Devices segment was the standout performer. Sales for the segment reached $5.37 billion, up 13.4%, with especially strong contributions from Diabetes Care, Heart Failure, Structural Heart, and Electrophysiology subsegments. Continuous glucose monitoring systems, like the FreeStyle Libre, generated $1.9 billion in revenue -- up 21.4% on a reported basis -- helped by robust adoption in both the U.S. and international markets. New launches, such as Navitor for heart valves and AVEIR leadless pacemakers, also fueled growth.

Diagnostics segment sales came in at $2.17 billion, declining 1% from last year. The primary factor was a sharp drop in COVID-19 testing sales, now down to $55 million from $102 million a year earlier. Core Laboratory Diagnostics grew slightly, but ongoing price cuts from China’s volume-based procurement program pressured overall segment results. While diagnostics achieved roughly 7% growth outside China in Q1 2025, this did not fully make up for the shortfall in that market. CEO Robert Ford noted the challenge, highlighting that recent changes in Chinese procurement have led to lower prices without offsetting volume gains -- a departure from past patterns.

Nutrition revenue was $2.21 billion, up 2.9% on a reported basis. Adult Nutrition -- driven by Ensure and Glucerna brands -- grew 6.1% on a reported basis, while Pediatric Nutrition organic sales remained nearly flat, reflecting a continuing squeeze in international pediatric sales, which fell 5.7%. The adult product growth offset ongoing softness in pediatric lines. Pharmaceutical sales, mostly in established branded generics outside the United States, rose 6.9% on a reported basis, with double-digit gains in emerging markets across Asia, Latin America, and the Middle East.

Adjusted operating margin rose to 22.9%, a 100 basis point increase from the prior year. Management cautioned that tariffs introduced in 2025 posed a “few hundred million dollar” headwind for the second half of the year, but indicated that mitigation strategies -- such as adjusting manufacturing footprints and leveraging foreign exchange rates -- remain in progress. Net earnings reached $2.21 billion. Abbott Laboratories also maintained a quarterly dividend of $0.59 per share, extending its streak of increases to 53 consecutive years.

Future Outlook and What to Watch

Looking ahead, management reaffirmed its full-year guidance despite new tariff costs. For fiscal 2025, it projects organic sales growth (excluding COVID-19 testing-related sales) of 7.5% to 8.0%, and full-year adjusted EPS in the $5.10–$5.20 range. Third-quarter 2025 adjusted EPS is expected to be between $1.28 and $1.32. Abbott also guided to an adjusted operating margin of 23.5%, implying further focus on efficiency and cost controls. Management sees new product launches and recovery in underperforming segments as growth drivers for the back half of 2025.

Investors should closely monitor the ongoing impact of global tariffs, continued performance in the Diagnostics segment -- especially in China -- and the pace at which the company launches new products in its medical devices pipeline. International pediatric nutrition trends also bear watching, given ongoing weakness. Planned mitigation efforts around tariffs and supply chain reshuffling, along with the evolving clinical and regulatory landscape, are likely to influence the company’s performance as 2025 progresses.

Note: Revenue and net income are presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,059%* — a market-crushing outperformance compared to 180% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool has a disclosure policy.

Fifth Third Bancorp Raises 2025 Outlook

Fifth Third Bancorp(NASDAQ:FITB) reported results for Q2 2025 on July 17, 2025, exceeding analysts' consensus expectations with adjusted (non-GAAP) EPS of $0.90, 6% adjusted revenue growth year over year, and 7% net interest income (NII) growth year over year. Management raised full-year NII and operating leverage guidance, announced that share repurchases will resume in Q3 2025, and emphasized resilience in both balance sheet positioning and strategic expansion in the Southeast.

Record Profitability Amidst Industry Headwinds

While regional banks broadly faced muted loan growth due to a soft housing market and uneven commercial demand, Fifth Third Bancorp's results were driven by strength across its commercial (C&I), CRE, leasing, mortgage, home equity, auto, and proprietary fintech channels. Its efficiency ratio improved to 55.5%, with tangible book value per share increasing 18% year over year and 5% sequentially, supported by prudent risk management and targeted investments.

"Our key profitability metrics continue to be very strong, and among the best of all peers who have reported thus far. Our adjusted return on assets was 1.2%. Our adjusted return on tangible common equity was 18%. And our efficiency ratio was 55.5%."
— Tim Spence, Chairman, CEO & President

Its consistently top-tier profitability and efficiency highlight a sustainable, well-diversified business model that reinforces long-term shareholder value regardless of macro uncertainties.

Southeast Expansion Accelerates Granular Growth

In the Southeast, 10 branches were opened in the first half of 2025, and 40 more are planned by year's end. Branches opened between 2022 and 2024 averaged over $25 million in deposits in their first year. The company is on pace to reach nearly 400 branches in the Southeast by year's end and has already secured approximately 80% of locations for an additional 200-branch buildout.

"Branches built between 2022 and 2024 are averaging over $25 million in deposit balances within the first 12 months after opening, significantly outpacing our original expectations. We remain on pace to open 50 branches this year, with 10 opened in the first half. We have now secured approximately 80% of the locations for the additional 200 Southeast branches that we announced in November."
— Bryan Preston, CFO

The strong deposit-gathering productivity of new Southeast branches supports strategic funding flexibility.

Innovative Payments and Tech Offerings Drive Fee Momentum

Fee income from Newline, the bank’s embedded payments business, increased 30% year over year, and new commercial deposits attached to Newline services grew by $1.1 billion year over year to $3.7 billion. J.D. Power recently ranked Fifth Third's mobile app No. 1 among regional banks for user satisfaction.

"Our embedded payments business, Newline, continued its strong growth with fees up 30%. Deposits attached to Newline services increased to $3.7 billion, up $1.1 billion compared to the year-ago period."
— Bryan Preston, CFO

Scaling digital and payments revenues through proprietary platforms and partnerships enhances fee income resiliency while growing low-cost, technology-driven commercial deposit relationships outside traditional branch channels.

Looking Ahead

Management raised its full-year NII growth guidance to 5.5% to 6.5%, and affirmed its expectations for record NII and 150 to 200 basis points of full-year positive operating leverage, even with no rate cuts or further loan growth. Average total loans are expected to be up 5% for the full year compared to 2024, driven by C&I and auto, with credit costs now projected in a tightened 43 to 47 basis point range for full-year net charge-offs. No specific M&A plans were outlined, and organic Southeast expansion remains the primary growth lever.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,059%* — a market-crushing outperformance compared to 180% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Ur-Energy: 35% Production Jump in Q2

Key Points

  • - Revenue for the second quarter of 2025 was $10.4 million, beating the analyst estimate of $7.10 million by 46.6%.

  • - Production at Lost Creek ramped up significantly, with dried and packaged pounds up 35% compared to Q1 2025.

  • - No earnings-per-share or cost/margin data was disclosed, limiting insight into profitability or cash generation.

Ur-Energy (NYSEMKT:URG), a uranium miner focused primarily in Wyoming, reported its latest earnings on July 15, 2025, covering results for the second quarter of 2025. The headline result was a Q2 2025 revenue figure of $10.4 million, well above analyst expectations of $7.1 million, thanks to higher-than-expected sales volumes and strong realized uranium prices. The company did not disclose net income, operating expenses, or earnings per share, limiting visibility into its overall profitability during the period. The quarter showed clear operational progress at both the Lost Creek site and development-stage Shirley Basin, with robust output and continued construction.

MetricQ2 2025Q2 2025 Estimate
EPSNot disclosed$(0.01)
Revenue$10.4 million$7.1 million
Pounds U3O8 Sold165,000
Average Realized Price per Pound U3O8$63.20
Pounds Dried & Packaged112,033

Source: Analyst estimates provided by FactSet. The company did not provide net earnings, operating expenses, or margin figures.

Company Overview and Business Focus

Ur-Energy is a uranium mining firm that operates the Lost Creek in situ recovery facility in Wyoming, with expansion underway at the Shirley Basin project and ongoing exploration in the Great Divide Basin. In situ recovery (ISR) is a mining technique that extracts uranium through wells by circulating solutions underground, offering relatively low-cost and environmentally sensitive production compared to traditional mining. The company's core business rests on producing uranium in the United States to meet the needs of utilities and the broader nuclear energy market.

Recently, the company has targeted higher production output, expanded its operational capabilities, and advanced the Shirley Basin development in anticipation of future demand. Its success hinges on mastering operational efficiency, maintaining strict regulatory compliance, and financially prudent expansion—especially important given the tight environmental oversight and volatile uranium pricing that dominate the sector. Contracting with utilities at favorable terms and keeping costs in check remain key measures of performance.

Notable Developments and Operational Performance This Quarter

The period saw meaningful progress at Lost Creek. Dried and packaged uranium output reached 112,033 pounds in Q2 2025, an increase of 35% over the first quarter of 2025. Total captured uranium production for the first half of the year was 203,449 pounds, up 73% from Q1 2025. This higher production was matched by increased shipments—105,316 pounds—and culminated in 165,000 pounds sold, all at an average realized price of $63.20 per pound. This unit price reflects current market dynamics; uranium prices have rallied and allowed producers to secure more advantageous sales contracts.

Operational upgrades played a notable role in the quarter’s results. The company reported a 27% rise in wellfield flow rates—a measure of the volume of solution moved through the production field—now exceeding 3,400 gallons per minute. Upgrades to plant systems, including filter press equipment and water treatment infrastructure, were completed. The combination of higher flow rates and sustained “head grade,” the uranium concentration in the production solution, held steady at over 70 milligrams per liter during May and June. This boosted overall capture and packaging rates.

The development project at Shirley Basin advanced on several fronts. Construction continued on the satellite processing pad, key equipment orders moved forward, and on-site utilities upgrades progressed to support future operations. Staff additions continued in line with construction milestones, with new operational hires expected by early October 2025. The company noted that initial uranium output at Shirley Basin is targeted for early 2026, pending regulatory inspection and operational ramp-up.

The company’s inventory position at Q2 2025 was 315,607 pounds of finished uranium stored at an offsite conversion facility and an additional 55,000 pounds held in process at Lost Creek. The company did not provide net earnings, operating expenses, or margin figures.

Outlook and What to Watch

Looking ahead, management commented that production levels at Lost Creek are expected to rise through the summer as additional wellfield “header houses,” small control and collection buildings, become operational. The Shirley Basin development is reportedly on schedule, with the goal of bringing its first pounds of uranium into production soon after regulatory approvals in early 2026. Additional drilling and exploration are planned for three new targets in the Great Divide Basin later this year.

The company’s leadership instead focused its commentary on operational milestones and ongoing construction progress. Investors and observers will likely keep a close eye on whether production momentum continues, how quickly Shirley Basin ramps up, and whether further uranium sales contract wins are secured amid price volatility.

Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,059%* — a market-crushing outperformance compared to 180% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Received before yesterday

Stock Market Today: Nu Holdings Rises on Fresh Analyst Optimism


Nu Holdings (NYSE: NU) shares rose 3.6% today, closing at $13.54 after trading between $13.12 and $13.54 during the day. The fintech company's stock rallied amid growing analyst confidence, with several Wall Street firms raising their price targets modestly over the past week. The consensus view appears increasingly optimistic about Nu's execution in the competitive Latin American digital banking space.

The stock outperformed both the Nasdaq Composite, up 0.18%, and the S&P 500's 0.4% drop, with trading volume coming in at approximately 123 million shares -- double the 50-day average of 84.5 million.

Industry peers also showed gains, In the competitive landscape, Inter & Co (NASDAQ: INTR) rose 4% to $7.05, trading between $6.80 and $7.06, showing similar strength following recent earnings and supportive central bank signals for digital lenders. Meanwhile, StoneCo (NASDAQ: STNE) declined 2% to $14.87 despite the year's broader tech momentum.

Despite today's gains, Nu stock still trades 16% below its 52-week high of around $16.14, though the trend has distinctly shifted upward as analyst sentiment improves. The favorable reassessments appear driven by Nu's accelerating user metrics and promising early results from its credit card and loan offerings in new Latin American markets, potentially setting the stage for further price target revisions if execution remains strong.

Should you invest $1,000 in Nu Holdings right now?

Before you buy stock in Nu Holdings, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nu Holdings wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $680,559!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,005,670!*

Now, it’s worth noting Stock Advisor’s total average return is 1,053% — a market-crushing outperformance compared to 180% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of July 15, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has positions in and recommends StoneCo. The Motley Fool recommends Nu Holdings. The Motley Fool has a disclosure policy.

Stock Market Today: BigBear.ai Rises 2.6% Global AI Momentum


BigBear.ai Holdings Inc.
(NYSE: BBAI) shares gained 2.6% to close at $7.10 on Monday, adding $0.18 per share as investors continued to respond positively to the company's recent strategic initiatives in aviation security. The stock has been gaining momentum following last month's announcement of a significant collaboration with Analogic, a global innovator in aviation security systems.

Trading volume spiked dramatically to approximately 134 million shares, representing an 8% increase over recent norms and suggesting substantial institutional interest in the company's expanding footprint in critical infrastructure security. The stock traded within an intraday range of $6.68 to $7.17. Despite today's gains, BBAI continues to trade below its all-time high of $12.69, indicating potential recovery room for the AI decision intelligence specialist.

The partnership with Analogic integrates BigBear.ai's advanced computer vision screening capabilities with Analogic's cutting-edge Computed Tomograph (CT) scanner technology, enhancing threat detection at airports worldwide through the Pangiam Threat Detection and Decision Support Platform. This collaboration aims to provide real-time, AI-driven threat detection insights to airport security teams.

In comparison, direct competitors showed mixed performance. Palantir Technologies dipped 0.38% to $148.58, while C3.ai posted a modest gain of 0.86% to close at $27.03.

Should you invest $1,000 in BigBear.ai right now?

Before you buy stock in BigBear.ai, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and BigBear.ai wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $680,559!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,005,670!*

Now, it’s worth noting Stock Advisor’s total average return is 1,053% — a market-crushing outperformance compared to 180% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of July 15, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool recommends C3.ai. The Motley Fool has a disclosure policy.

Stock Market Today: Nvidia Climbs on China GPU Export Resumption


Nvidia
(NASDAQ: NVDA) shares surged 4% to close at $170.70 on Tuesday, outpacing broader market indices as investors responded positively to news about graphics processing unit (GPU) exports to China resuming. The chipmaker received assurances from the Trump administration that it can once again export its H20 GPU to the Chinese market.

While Nvidia rallied, major indices showed mixed performance. The S&P 500 fell slightly, dropping 0.4%, while the Nasdaq Composite remained relatively flat with its 0.18% gain, highlighting Nvidia's strong individual performance against market headwinds. Among competitors, Advanced Micro Devices (NASDAQ: AMD) showed even stronger performance, jumping 6.4% to $155.61, while Intel (NASDAQ: INTC) declined 1.63% to $22.92, highlighting the diverging fortunes within the semiconductor sector.

Nvidia's trading volume reached approximately 229 million shares, below its 200-day average of approximately 253 million shares, according to Barchart data. Technically, the stock has established positive momentum by reclaiming its 200-day moving average of around $131.40, with the shares now trading nearly 30% above this key technical indicator.

The company's renewed access to the crucial Chinese market, combined with ongoing sector rotation into artificial intelligence (AI) infrastructure investments, appears to be solidifying Nvidia's position as the premier semiconductor manufacturer in the rapidly expanding AI space.

Should you invest $1,000 in Nvidia right now?

Before you buy stock in Nvidia, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $680,559!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,005,670!*

Now, it’s worth noting Stock Advisor’s total average return is 1,053% — a market-crushing outperformance compared to 180% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of July 15, 2025

JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices, Intel, and Nvidia. The Motley Fool recommends the following options: short August 2025 $24 calls on Intel. The Motley Fool has a disclosure policy.

Albertsons Q1 Sales Up on Digital Growth

Albertsons Companies (NYSE:ACI) reported first quarter 2025 results on July 15, 2025, with same-store sales growth of 2.8%, adjusted EBITDA of $1.11 billion, and adjusted EPS of $0.55, but lower year-over-year profitability. Management raised its FY2025 same-store sales growth outlook to 2%–2.75%, driven by outsized pharmacy and digital gains, while reiterating its unchanged adjusted EBITDA and adjusted EPS guidance for FY2025.

Key strategic developments this quarter provide insight into digital transformation progression, margin dynamics, and execution of the cross-shopping flywheel.

Accelerated Digital and E-commerce Momentum, Near Breakeven Profitability

Albertsons’ e-commerce revenue grew 25% year over year and accounted for 9% of total grocery sales, although penetration is still below peers. Investments in digital capabilities, proprietary mobile apps, and interactive features support rapid customer adoption and ongoing engagement across omni-channel touchpoints.

"Our first digital platform is e-commerce, which grew 25% and reached 9% of total grocery revenue in the first quarter. This growth was again led by strong performance in our first-party business, driven by award-winning capabilities and our fully integrated mobile app, and supported by our five-star certification program."
— Susan Morris, CEO

E-commerce scale and operational leverage, combined with a store-based fulfillment model, are driving efficiencies in Albertsons' operations.

Sustained Pharmacy Outperformance Drives Top-Line Growth Amid Normalizing Margins

Pharmacy and health platform sales surged 20%, with GLP-1 medications contributing half of pharmacy comp growth, and non-GLP-1 script growth was also robust. Increased store traffic from pharmacy customers is a central engine of incremental long-term customer value, and Albertsons has opened its third central fill facility to further increase pharmacy efficiency.

"The ongoing integration of pharmacy and Sincerely Health into our overall digital experience. Cross-shoppers between grocery and pharmacy are exceptionally valuable. Over time, these customers visit the store four times more often and buy significantly more groceries with us, resulting in outsized customer lifetime value."
— Susan Morris, CEO

Unique integration of pharmacy and grocery supports recurring visits and customer stickiness, yet persistent mix shift toward pharmacy creates ongoing margin pressure until optimization and cross-shopping gains are fully realized.

Margin Headwinds Offset by Productivity Programs and Strategic Pricing Investments

Gross margin, excluding fuel and legal expense, declined 85 basis points due to incremental investments in the customer value proposition and the mix shift impact related to the strong growth in pharmacy and digital businesses, although partially offset by shrinkage and productivity gains. National buying initiatives and automation are expected to provide gross margin tailwinds in the second half of FY2025, while selling and administrative expense rates improved by 63 basis points year over year, driven by productivity actions and reduced merger-related costs.

"As we think about Q1, it was actually one of our largest overlaps year over year. And thus the compare that you're seeing from the gross margin investment. That said, as I mentioned before, we're gonna continue to invest in margin, but we also expect our productivity to begin to provide a tailwind as our national buying gradually kicks in as the year progresses."
— Susan Morris, CEO

The balance between volume-driven price investment and cost reduction initiatives will determine whether Albertsons can stabilize margins and sustain profit growth in the face of elevated competitive intensity and labor inflation.

Looking Ahead

Management raised same-store sales growth guidance for fiscal 2025 to 2%–2.75% and expects adjusted EBITDA of $3.8 billion to $3.9 billion for FY2025, with Q2 FY2025 comparable sales anticipated at the low end of the range before accelerating in the second half. Adjusted EPS (non-GAAP) guidance for FY2025 remains at $2.16–$2.30, including $0.03 from the extra week, with capital expenditures unchanged at $1.7 billion to $1.9 billion for FY2025. For fiscal 2026, the company continues to target long-term identical sales growth of 2% or more and adjusted EBITDA growth (non-GAAP) exceeding sales in FY2026.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 1,053%* — a market-crushing outperformance compared to 180% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of July 14, 2025

This article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

❌